BELLUS Health Inc. (BLU) Social Stream



BELLUS Health Inc. (BLU): $11.59

-0.41 (-3.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BLU to Watchlist
Sign Up

Industry: Biotech


Ranked

of 404

in industry

BELLUS Health Inc (BLU) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BLU.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 8 $16 $7.5 $11.071 $6.24 77.42%
2021-12-07 7 $16 $7.5 $11.25 $6.24 80.29%
2021-12-14 8 $20 $7.5 $13.687 $6.24 119.34%
2022-01-24 8 $20 $7.5 $13.562 $6.24 117.34%
2022-02-02 8 $20 $9 $14.625 $6.24 134.38%
2022-02-25 8 $20 $9 $14.875 $6.24 138.38%

The Trend in the Analyst Price Target


BLU's average price target has moved up $7.68 over the prior 30 weeks.

BLU reports an average of 87.88% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-27 7 10 2.6 6.320 3.98 58.79%
2021-07-29 7 10 4.8 7.200 2.86 151.75%
2021-10-18 8 16 7.5 11.071 6.28 76.29%
2021-12-14 8 20 7.5 13.687 8.19 67.12%
2022-02-02 8 20 9.0 14.625 6.67 119.27%

BLU Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.13 7 1 0 0 0 8

The Trend in the Broker Recommendations


Over the past 62 days, BLU's average broker recommendation rating improved by 0.02.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • BELLUS Health Inc's average analyst price target is greater than 99.89% of all US stocks.
  • BELLUS Health Inc's variance in analysts' estimates is lower than -591.13% of all US stocks.
  • BLU has a greater number of analysts covering the stock than 730.36% of stocks in the small market cap category.
  • BLU has a higher upside potential (average analyst target price relative to current price) than 272.85% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BELLUS Health Inc are BLCM, BIVI, and BCYC.

What is the outlook for BLU? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.2806 seconds.